|
|
|
| Pharmaceutical and healthcare market in Poland 2009 |
|
| Table of Contents Published: 2009/06 Published by: PMR |
| The latest report from PMR - Pharmaceutical and Healthcare Market in Poland 2009 - provides information on the size of the pharmaceutical market in Poland in 2002-2008 and market size projections for 2009-2011. The main forecasts estimate the size of the ... |
| Brands & Strategies: Alzheimer's Disease |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| In 2007, the Alzheimer' s disease (AD) market, valued at more than $3 billion in the United States, Europe, and Japan, was led by sales of Eisai/Pfizer' s Aricept. The growth of all the currently available agents will decline by the end of our forecast, a ... |
| 2008/2009 Healthcare Research Review |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| BCC Research has provided comprehensive coverage of healthcare technology markets for many years, and we are now in the process of increasing our production of healthcare-related technology market research reports. This review of healthcare research condu ... |
| Oncology Partnering Agreements in Pharma, Biotech and Diagnostics |
|
| Table of Contents Published: 2009/06 Published by: CurrentPartnering, a division of Wildwood Ventures Limited |
| The Oncology Partnering Agreements in Pharma, Biotech and Diagnostics report provides comprehensive understanding and unprecedented access to the oncology partnering agreements entered into by the worlds leading biopharma companies.
The report provide ... |
| U.S. Injectable Drug Pipeline |
|
| Table of Contents Published: 2009/06 Published by: Frost & Sullivan |
| This research service covers the U.S. injectable drug pipeline in 2009. Included are technology trends, Phase III pipeline analysis, selected Phase II and I pipeline analysis. The market is segmented by injectable drug delivery route: subcutaneous injecta ... |
| Pakistan Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| Pakistan' s pharmaceutical expenditure was valued at PKR127bn (US$2bn) in 2008. Between 2009 and
2013, BMI forecasts that the market should grow at a nominal CAGR of 12.7% in local currency to reach
PKR230bn (US$3bn) in 2013, with population growth bein ... |
| Nigeria Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| In BMI' s Q309 update of the Pharmaceutical Business Environment Rankings for the Middle East and
Africa (MEA) region, Nigeria is once again ranked second-last out of the 17 key regional markets, above
only Zimbabwe. Globally, Nigeria is also ranked sec ... |
| Kenya Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| BMI calculates Kenya' s pharmaceutical expenditure to have been KES15.85bn (US$229mn) in 2008. By
2013, we expect the total amount spent on prescription and over-the-counter (OTC) medicines to have
reached a value of KES29.89bn (US$395mn) equating to a ... |
| Jordan Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| BMI has revised its extended forecast for Jordan' s pharmaceutical and healthcare market for our Q309
report. We expect the total drug market to grow from US$370mn in 2008 to US$519mn by 2013,
representing a compound annual growth rate (CAGR) of 7.01%. ... |
| Iran Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| For BMI' s Q309 Iran Pharmaceutical and Healthcare Report, we expect a 9.0% compound annual growth
rate (CAGR) for the total pharmaceutical market, meaning an increase in total value from US$2.27bn in
2008 to US$3.50bn by 2013. We believe the main drive ... |
| Australia Pharmaceuticals and Healthcare Report Q3 2009 |
|
| Table of Contents Published: 2009/06 Published by: Business Monitor International |
| In 2008, Australia' s pharmaceutical market was worth US$7bn. BMI expects the pharma industry to post
modest growth over the forecast period, with a CAGR of 3.2% between 2008-2013, in local currency
terms. Growth will be largely due to the market' s hig ... |
| The World Pharmaceutical Markets Fact Book 2009 |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Published by Espicom, for over 28 years experts in the healthcare market field, the 324-page Fact Book brings together a range of often difficult to source information in one single, convenient and comprehensive publication. Keep it near to you at all tim ... |
| Chinese Markets for Pharmaceutical Packaging |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| China' s demand for Pharmaceutical Packaging has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developm ... |
| Chinese Markets for Leukemia Treatment Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| China' s demand for Leukemia Treatment Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry developm ... |
| Chinese Markets for Anti-Infectious Disease Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| China' s demand for Anti-Infectious Disease Drugs has grown at a fast pace in the past decade. In the next five years, both production and demand will continue to grow. This new study examines China' s economic trends, investment environment, industry dev ... |
| Chinese Markets for Pain and Fever Relief Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-te ... |
| Chinese Markets for Hepatitis Treatment Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-te ... |
| Chinese Markets for Blood Disease Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-te ... |
| Chinese Markets for Asthma Treatment Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-t ... |
| Chinese Markets for Arthritis Treatment Drugs |
|
| Table of Contents Published: 2009/06 Published by: Asia Market Information & Development Co. |
| This new study examines China' s economic trends, investment environment, industry development, supply and demand, industry capacity, industry structure, marketing channels and major industry participants. Historical data (1998, 2003 and 2008) and long-te ... |
| New Strategies in Academic-Industry Collaborations |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| Major pharmaceutical companies are showing increased interest in directly sponsoring academic research to access innovation and fill dwindling pipelines. Recent agreements involve higher levels of collaboration and funding, are broader in scope, and focus ... |
| Autoimmune Market Forecast to 2014 |
|
| Table of Contents Published: 2009/06 Published by: Cutting Edge Information |
| From sales projections to clinical trial data to analysts' insights, Autoimmune Market Forecast to 2014 tells you everything you need to know. Unlike other market forecast reports out there, ours covers all of the major indications - rheumatoid arthritis, ... |
| Biosimilars Series: Forecast Analysis |
|
| Table of Contents Published: 2009/06 Published by: Datamonitor |
| The high cost and utilization of biologic drugs, coupled to the growing need to curb pharmaceutical expenditure, provides considerable momentum to the emerging biosimilars market. With a biosimilar approval pathway in place in Europe and Japan, and immine ... |
| Healthcare Information Technology |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| This report is an analytical business tool whose primary purpose is to describe and analyze the dynamics of the U.S. market for health care technology. It is particularly focused on clinical IT systems that facilitate or provide input into the care proces ... |
| Liver Disease Treatments: The Global Market |
|
| Table of Contents Published: 2009/06 Published by: BCC Research |
| BCC' s goal in conducting this study is to provide an overview of the current and potential aspects of the global market for liver diseases treatments. The report determines the market size and market leaders, provides a market overview, and examines fact ... |
| EMERGING MEDICAL TECHNOLOGIES REPORT |
|
| Table of Contents Published: 2009/06 Published by: Life Science Intelligence, Inc. |
| This 1000+ page report includes detailed 2-3 page executive summaries on 522 emerging medical device companies who have either presented at a Medtech Insight In3 investor/partnering conference or at an LSI (EMT) Emerging Medical Technologies Spotlight. ... |
| Mega-Mergers: Executing Change in the Pharma Industry |
|
| Table of Contents Published: 2009/06 Published by: Decision Resources, Inc. |
| If consolidation is so advantageous for boosting a pharma company to a new level of productivity, why has Pfizer engaged in not just one but three mega-mergers in the past ten years: $92.3 billion for Warner-Lambert in 2000, $60 billion for Pharmacia in 2 ... |
| Global Diabetes Market |
|
| Table of Contents Published: 2009/06 Published by: Frost & Sullivan |
| This research services details the market drivers, restraints, challenges, revenue forecasts of the insulin and the no-insulin market segments of the global diabetes market. It also deals with regional analysis of the US, Europe, Japan and rest of the wor ... |
| Allergy Drug Pipeline and R&D 2009 |
|
| Table of Contents Published: 2009/06 Published by: Fuji-Keizai U.S.A., Inc. |
| This report describes current global research initiatives in the field of allergies. It focuses on the most common allergies, which affect more than 300 million persons worldwide: seasonal and perennial allergic rhinitis and food allergies. ... |
| Therapeutic Monoclonal Antibodies Markets |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Antibodies are proteins in the immune system that help the body defend against foreign invasion, particularly from pathogens and toxins. As such, a human-engineered therapeutic monoclonal antibody (mAb) is protein derived from the immune system through re ... |
| Pharmacogenomics for Clinical Use and in Drug Development |
|
| Table of Contents Published: 2009/06 Published by: Trimark Publications |
| Pharmacogenomics, the science of individualizing drug therapy based on the genetic makeup of individual patients, offers an unusual opportunity for future market growth. Applying pharmacogenomics would allow doctors to treat specific segments of the popul ... |
| Roche: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Roche achieved strong sales results in 2007, coupled with a significant improvement in operating profitability, however, this performance could not be replicated as the company felt the effects of the global economic crisis, as well as a significant downt ... |
| Merck KGaA: Pipeline, Products, Performance, Potential |
|
| Table of Contents Published: 2009/06 Published by: Espicom Business Intelligence |
| Merck' s pharmaceutical operations are divided into the Merck Serono business and Consumer Health Care. For the former, research and marketing efforts are centred on two key therapeutic areas, namely Oncology and Neurology. ... |
|
|
|
View Cart
Top